Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair... Show more
a provider of products and technologies for peripheral nerve reconstruction and regeneration
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MMID | 25.77 | 0.25 | +1.00% |
| MFS Active Mid Cap ETF | |||
| BGH | 13.93 | 0.09 | +0.65% |
| Barings Global Short Duration High Yield Fund | |||
| DSTL | 59.98 | 0.28 | +0.48% |
| Distillate US Fdmtl Stblty & Val ETF | |||
| NSCI | 25.14 | 0.01 | +0.04% |
| Nuveen Securitized Income ETF | |||
| XRMI | 17.15 | -0.05 | -0.30% |
| Global X S&P 500® Risk Managed Inc ETF | |||
A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with TMDX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then TMDX could also see price increases.
| Ticker / NAME | Correlation To AXGN | 1D Price Change % | ||
|---|---|---|---|---|
| AXGN | 100% | +3.35% | ||
| TMDX - AXGN | 38% Loosely correlated | +4.43% | ||
| XRAY - AXGN | 36% Loosely correlated | +2.05% | ||
| ITGR - AXGN | 31% Poorly correlated | +2.41% | ||
| CLPT - AXGN | 31% Poorly correlated | +1.49% | ||
| GMED - AXGN | 31% Poorly correlated | +5.39% | ||
More | ||||
| Ticker / NAME | Correlation To AXGN | 1D Price Change % |
|---|---|---|
| AXGN | 100% | +3.35% |
| Health Services category (247 stocks) | 9% Poorly correlated | -0.29% |
| Medical/Nursing Services category (139 stocks) | 8% Poorly correlated | -0.47% |
AXGN saw its Momentum Indicator move above the 0 level on June 05, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on June 09, 2026. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .
AXGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for AXGN moved out of overbought territory on May 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for AXGN entered a downward trend on June 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.311) is normal, around the industry mean (10.958). P/E Ratio (0.000) is within average values for comparable stocks, (63.629). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.746). AXGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (8.576) is also within normal values, averaging (26.468).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.